Table of contents
Volume 90, Issue 4
Published online 17 February 2004 (747-939)
Review |
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letters to the Editor
Minireviews
SNPs in cancer research and treatment FREE
H C Erichsen and S J Chanock
Br J Cancer 90: 747-751; doi:10.1038/sj.bjc.6601574
Host genetics and tumour metastasis FREE
K W Hunter
Br J Cancer 90: 752-755; doi:10.1038/sj.bjc.6601590
ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia FREE
E Canaani, T Nakamura, T Rozovskaia, S T Smith, T Mori, C M Croce and A Mazo
Br J Cancer 90: 756-760; doi:10.1038/sj.bjc.6601639
Review
Linking the epigenetic 'language' of covalent histone modifications to cancer FREE
S B Hake, A Xiao and C D Allis
Br J Cancer 90: 761-769; doi:10.1038/sj.bjc.6601575
Clinical
Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma FREE
R M MacKie and C A Bray
Br J Cancer 90: 770-772; doi:10.1038/sj.bjc.6601595
Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma FREE
M Lotem, E Shiloni, I Pappo, O Drize, T Hamburger, R Weitzen, R Isacson, L Kaduri, S Merims, S Frankenburg and T Peretz
Br J Cancer 90: 773-780; doi:10.1038/sj.bjc.6601563
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy FREE
P S Murphy, L Viviers, C Abson, I J Rowland, M Brada, M O Leach and A S K Dzik-Jurasz
Br J Cancer 90: 781-786; doi:10.1038/sj.bjc.6601593
Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer FREE
S Suzuki, T Akechi, M Kobayashi, K Taniguchi, K Goto, S Sasaki, S Tsugane, Y Nishiwaki, H Miyaoka and Y Uchitomi
Br J Cancer 90: 787-793; doi:10.1038/sj.bjc.6601621
Is treatment with interferon-
effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions FREE
P Royston, W Sauerbrei and A Ritchie
Br J Cancer 90: 794-799; doi:10.1038/sj.bjc.6601622
A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours FREE
L Wall, D C Talbot, P Bradbury and D I Jodrell
Br J Cancer 90: 800-804; doi:10.1038/sj.bjc.6601594
Photodynamic detection of diseased axillary sentinel lymph node after oral application of aminolevulinic acid in patients with breast cancer FREE
K A Frei, H M Bonel, H Frick, H Walt and R A Steiner
Br J Cancer 90: 805-809; doi:10.1038/sj.bjc.6601615
A phase II study of sequential carboplatin, paclitaxel and topotecan in patients with previously untreated advanced ovarian cancer FREE
A E Guppy, A E Nelstrop, T Foster, R Agarwal, M J Seckl and G J S Rustin
Br J Cancer 90: 810-814; doi:10.1038/sj.bjc.6601618
Molecular and Cellular Pathology
Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma FREE
W Weichert, C Denkert, M Schmidt, V Gekeler, G Wolf, M Köbel, M Dietel and S Hauptmann
Br J Cancer 90: 815-821; doi:10.1038/sj.bjc.6601610
Tumour-derived TGF-
1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells FREE
M P Lewis, K A Lygoe, M L Nystrom, W P Anderson, P M Speight, J F Marshall and G J Thomas
Br J Cancer 90: 822-832; doi:10.1038/sj.bjc.6601611
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma FREE
P Pontisso, F Calabrese, L Benvegnù, M Lise, C Belluco, M G Ruvoletto, S De Falco, M Marino, M Valente, D Nitti, A Gatta and G Fassina
Br J Cancer 90: 833-837; doi:10.1038/sj.bjc.6601543
Demethylation of MAGE promoters during gastric cancer progression FREE
T Honda, G Tamura, T Waki, S Kawata, M Terashima, S Nishizuka and T Motoyama
Br J Cancer 90: 838-843; doi:10.1038/sj.bjc.6601600
Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-
in haematopoietic tumour cells FREE
Y Morimoto, M Toyota, A Satoh, M Murai, H Mita, H Suzuki, Y Takamura, H Ikeda, T Ishida, N Sato, T Tokino and K Imai
Br J Cancer 90: 844-852; doi:10.1038/sj.bjc.6601602
Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function FREE
P Bhat-Nakshatri, R A Campbell, N M Patel, T R Newton, A J King, M S Marshall, S Ali and H Nakshatri
Br J Cancer 90: 853-859; doi:10.1038/sj.bjc.6601541
Genetics and Genomics
Identification and characterisation of constitutional chromosome abnormalities using arrays of bacterial artificial chromosomes FREE
J K Cowell, Y D Wang, K Head, J Conroy, D McQuaid and N J Nowak
Br J Cancer 90: 860-865; doi:10.1038/sj.bjc.6601588
Cellular responses to ionising radiation of AT heterozygotes: differences between missense and truncating mutation carriers FREE
M Fernet, N Moullan, A Lauge, D Stoppa-Lyonnet and J Hall
Br J Cancer 90: 866-873; doi:10.1038/sj.bjc.6601549
Promoter hypermethylation of MGMT, CDH1, RAR- and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin FREE
V S Dhillon, A R Young, S A Husain and M Aslam
Br J Cancer 90: 874-881; doi:10.1038/sj.bjc.6601567
Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer FREE
M Ponz de Leon, P Benatti, C Di Gregorio, M Pedroni, L Losi, M Genuardi, A Viel, M Fornasarig, E Lucci-Cordisco, M Anti, G Ponti, F Borghi, I Lamberti and L Roncucci
Br J Cancer 90: 882-887; doi:10.1038/sj.bjc.6601529
The CHEK2 *1100delC mutation has no major contribution in oesophageal carcinogenesis FREE
L B Koppert, M Schutte, M Abbou, H W Tilanus and W N M Dinjens
Br J Cancer 90: 888-891; doi:10.1038/sj.bjc.6601551
Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear -catenin expression FREE
L B Koppert, A W van der Velden, M van de Wetering, M Abbou, A M W van den Ouweland, H W Tilanus, B P L Wijnhoven and W N M Dinjens
Br J Cancer 90: 892-899; doi:10.1038/sj.bjc.6601589
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation FREE
H K Berrieman, J N E Ashman, M E Cowen, J Greenman, M J Lind and L Cawkwell
Br J Cancer 90: 900-905; doi:10.1038/sj.bjc.6601569
Experimental Therapeutics
Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice FREE
L-M Ching, S Zwain and B C Baguley
Br J Cancer 90: 906-910; doi:10.1038/sj.bjc.6601606
CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes FREE
R Schmidt, F Baumann, H Knüpfer, M Brauckhoff, L-C Horn, M Schönfelder, U Köhler and R Preiss
Br J Cancer 90: 911-916; doi:10.1038/sj.bjc.6601492
N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx FREE
R J Veldman, S Zerp, W J van Blitterswijk and M Verheij
Br J Cancer 90: 917-925; doi:10.1038/sj.bjc.6601581
Forced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth FREE
M-H Wang, M E Grossmann and C Y F Young
Br J Cancer 90: 926-931; doi:10.1038/sj.bjc.6601583
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents FREE
C R Ireson, S K Chander, A Purohit, S Perera, S P Newman, D Parish, M P Leese, A C Smith, B V L Potter and M J Reed
Br J Cancer 90: 932-937; doi:10.1038/sj.bjc.6601591
Letters to the Editor
Is CD1a involved in antitumour immune responses during carcinogenesis? FREE
F Cappello
Br J Cancer 90: 938; doi:10.1038/sj.bjc.6601597
Reply: Is CD1a involved in antitumour immune responses during carcinogenesis? FREE
B J Coventry and S Heinzel
Br J Cancer 90: 939; doi:10.1038/sj.bjc.6601598
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
